admin

November 5, 2019

Melbourne Australia;
5 November 2019 – Key United States Patent covering OBM-1701 Granted

Oculus Biomed Limited (“OBM”) is pleased to announce the grant of the USA Patent which covers its OBM-1701. The term of the Chinese patent extend its […]
August 31, 2018

Melbourne, Australia;
31 August 2018 – Batch of OBM-1701 was Successfully Manufactured with High Purity

Oculus Biomed Limited (“OBM”) is pleased to announce a batch of OBM-1701 has been successfully manufactured with the purity of 99.5% (as determined by the HPLC) […]